Characteristics of Patients With Thymoma in Chulalongkorn Hospital

Associated Disorders Clinical Trial

Official title:

Characteristics of Patients With Thymoma Undergone Thymectomy in Chulalongkorn Hospital Between 2003-2007

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01123590
• Other study ID #: Chula-ARC 003/09
• Status: Completed
• Phase: N/A
• First received: May 12, 2010
• Last updated: November 21, 2010
• Start date: November 2009
• Est. completion date: October 2010

Study information

• Verified date: November 2010
• Source: Chulalongkorn University
• Contact: n/a
• Is FDA regulated: No
• Health authority: Thailand: Ethical Committee
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to study characteristics of patients with thymoma in Chulalongkorn hospital between 2003-2007.

Description:

To study characteristics of patients with thymoma undergone thymectomy in Chulalongkorn hospital between 2003-2007 in terms of clinical manifestations, associated diseases, and laboratory findings.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 50
• Est. completion date: October 2010
• Est. primary completion date: April 2010
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Patients with histocytological proved thymoma undergone thymectomy in Chulalongkorn hospital between 2003-2007

Exclusion Criteria:

Study Design

Observational Model: Case Control, Time Perspective: Retrospective

Related Conditions & MeSH terms

• Associated Disorders
• Clinical Presentations
• Laboratory Findings
• Thymoma
• Thymoma Staging
• Thymus Neoplasms

Locations

Country	Name	City	State
Thailand	Faculty of Medicine, Chulalongkorn University	Bangkok

Sponsors (1)

Lead Sponsor	Collaborator
Chulalongkorn University

Country where clinical trial is conducted

Thailand, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Thymoma staging and clinical manifestations		5 years	No
Secondary	Associated diseases and laboratory findings Immunological data		4 months	No